Related references
Note: Only part of the references are listed.Comparative study of skin autofluorescence expression in atopic dermatitis and psoriasis: A prospective in vivo study
J. H. Yim et al.
SKIN RESEARCH AND TECHNOLOGY (2017)
Skin autofluorescence is associated with arterial stiffness and insulin level in endurance runners and healthy controls - Effects of aging and endurance exercise
Christian Couppe et al.
EXPERIMENTAL GERONTOLOGY (2017)
Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations
Cidila Da Moura Semedo et al.
POSTGRADUATE MEDICAL JOURNAL (2017)
Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study
Nadia Botros et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study
Marcelle G. A. van Eupen et al.
HYPERTENSION (2016)
Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus
M. Genevieve et al.
DIABETES & METABOLISM (2013)
Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes
Andries J. Smit et al.
PLOS ONE (2013)
Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction
A. S. Januszewski et al.
DIABETIC MEDICINE (2012)
Advanced protein glycation in psoriasis
A. Damasiewicz-Bodzek et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Advanced glycation end products measured by skin autofluorescence in a population with central obesity
Corine den Engelsen et al.
DERMATO-ENDOCRINOLOGY (2012)
Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation
K-H. Yiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Dermal Factors Influencing Measurement of Skin Autofluorescence
Margaretha J. Noordzij et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity
Wolf-Henning Boehncke et al.
EXPERIMENTAL DERMATOLOGY (2011)
Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients
Makio Nagano et al.
NEPHROLOGY (2011)
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease
Lodewijk de Groot et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease
Andries J. Smit et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Batya B. Davidovici et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community
A. Menter et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis
Hans L. A. Nienhuis et al.
AUTOIMMUNITY (2009)
Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events
D. J. Mulder et al.
NETHERLANDS HEART JOURNAL (2009)
Psoriasis and diabetes: a population-based cross-sectional study
A. D. Cohen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Skin auto fluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease
Hiroki Ueno et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts
H. L. Nienhuis et al.
RHEUMATOLOGY (2008)
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
K. de Leeuw et al.
RHEUMATOLOGY (2007)
Skin autofluorescence is a strong predictor of cardiac mortality in diabetes
Robbert Meerwaldt et al.
DIABETES CARE (2007)
Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes
Helen L. Lutgers et al.
DIABETES CARE (2006)
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients
R Meerwaldt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
G Basta et al.
CARDIOVASCULAR RESEARCH (2004)
The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation
AJ Smit et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Share Paper
